FIREBRICKPHARMA ORDINARY (FRE) Short Interest
FIREBRICKPHARMA ORDINARY (ASX:FRE) had 0.01% of shares reported as short positions as of 7 July 2026, representing 19,206 shares. FIREBRICKPHARMA ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
FRE
Firebrick Pharma
Pharmaceuticals, Biotechnology & Life Sciences
Firebrick Pharma is a pharmaceutical development and manufacturing company focused on developing and commercializing nasal sprays based on povidone-iodine (PVP-I). Their lead product, Nasodine Nasal Spray, is intended as a treatment for the common cold. The company aims to bring Nasodine to the global market.
pharmaceuticals
biotechnology
nasal spray
povidone-iodine
Shorted
short percentage0.01%
reported shorts19.2K
shares on issue285.199M